In the era of the molecular classification of endometrial carcinoma, L1CAM appears to be expressed more often by p53-mutant tumors and to have an independent prognostic role only in heterogeneous groups with no specific molecular subtype. The gene discussed is TP53; the disease is endometrial carcinoma.